Salvage gastrectomy following a combination of biweekly paclitaxel and S-1 for stage IV gastric cancer

Journal of Gastrointestinal Surgery

Volumn 12, Issue 8, 2008, Pages 1370-1375

  Ishigami, Sumiya ^a   Natsugoe, Shoji ^a   Nakajo, Akihiro ^a   Matsumoto, Masataka ^a   Uenosono, Yoshikazu ^a   Arigami, Takaaki ^a   Setoyama, Tetsuro ^a   Arima, Hideo ^a   Uchikado, Yasuto ^a   Kita, Yoshiaki ^a   Sasaki, Ken ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Paclitaxel; S 1; Salvage surgery

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; OXONIC ACID; PACLITAXEL; S 1 (COMBINATION); TEGAFUR;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SALVAGE THERAPY; STOMACH TUMOR; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXONIC ACID; PACLITAXEL; SALVAGE THERAPY; STOMACH NEOPLASMS; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME;

EID: 48849106769     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0539-2     Document Type: Article

References (21)

1. Akiyoshi T, Kawaguchi M, Arinaga S, Miyazaki S, Koba F, Wada T, Tsuji H. Combination chemoimmunotherapy for advanced gastric carcinoma. Jpn J Surg 1984;14:185-190. Medline DOI 10.1007/BF02469566.
2. Ajani JA, Ota DM, Jackson DE. Current strategies in the management of locoregional and metastatic gastric carcinoma. Cancer 1991;67:260-265.
3. Rivera F, Vega-Villegas ME, López-Brea MF. Chemotherapy of advanced gastric cancer. Cancer Treat Rev 2007;33:315-324. Medline DOI 10.1016/j.ctrv.2007.01.004.
4. Koizumi W, Tanabe S, Saigenji K, Ohtsu A, Boku N, Nagashima F, Shirao K, Matsumura Y, Gotoh M. Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 2003;89:2207-2212. Medline DOI 10.1038/sj.bjc.6601413.
5. Inokuchi M, Yamashita T, Yamada H, Kojima K, Ichikawa W, Nihei Z, Kawano T, Sugihara K. Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer. Br J Cancer 2006;94:1130-1135. Medline DOI 10.1038/sj.bjc.6603072.
6. Yoshida K, Ninomiya M, Takakura N, Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M, Sakamoto J, Nishiyama M. Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clin Cancer Res 2006;12:3402-3407. Medline DOI 10.1158/1078-0432.CCR-05-2425.
7. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA, V325 Study Group. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006;24:4991-4997. Medline DOI 10.1200/JCO.2006.06.8429.
8. Hokita S, Aikou T, Miyazono F, Ishigami S, Aridome K, Maenohara S, Saihara T, Suenaga K, Nomura H, Maeda S, Takatori H, Arima H, Uchikado Y, Natsugoe S, Takao S. A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer. Cancer Chemother Pharmacol 2006;57:736-740. Medline DOI 10.1007/s00280-005-0122- 4.
9. Cooper A, DePriest P. Surgical management of women with ovarian cancer. Semin Oncol 2007;34:226-233. Medline DOI 10.1053/j.seminoncol.2007.03.010.
10. Sonpavde G, Hutson TE, Roth BJ. Management of recurrent testicular germ cell tumors. Oncologist 2007;12:51-61. Medline DOI 10.1634/theoncologist.12-1- 51.
11. Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Uenosono Y, Ishigami S, Owaki T, Aikou T. The role of salvage surgery for recurrence of esophageal squamous cell cancer. Eur J Surg Oncol 2006;32:544-547. Medline DOI 10.1016/j.ejso.2006.02.014.
12. Yano M, Shiozaki H, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Tsujinaka T, Monden M. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer. World J Surg 2002;26:1155-1159. Medline DOI 10.1007/s00268-002-6362-0.
13. Ott K, Sendler A, Becker K, Dittler HJ, Helmberger H, Busch R, Kollmannsberger C, Siewert JR, Fink U. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 2003;6:159-167. Medline DOI 10.1007/s10120-003- 0245-4.
14. Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Ohashi Y, Yanagisawa A. Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol 1997;4:203-208. Medline DOI 10.1007/BF02306611.
15. Nashimoto A, Yabusaki H, Tanaka O, Sasaki J, Akiyama N. Neoadjuvant chemotherapy in advanced gastric cancer with non-curative factors: a Phase II study with 5-fluorouracil, leucovorin, and cisplatin. Gastric Cancer 1999;2:57-63. Medline DOI 10.1007/s101200050022.
16. Gallardo-Rincón D, Oñate-Ocaña LF, Calderillo-Ruiz G. Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. Ann Surg Oncol 2000;7:45-50. Medline DOI 10.1007/s10434-000-0045-6.
17. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216. Medline DOI 10.1093/jnci/92.3.205.
18. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998;1:10-24. Medline.
19. Satoh S, Hasegawa S, Ozaki N, Okabe H, Watanabe G, Nagayama S, Fukushima M, Takabayashi A, Sakai Y. Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination. Gastric Cancer 2006;9:129-135. Medline DOI 10.1007/s10120-006-0369-4.
20. Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, Bottcher K, Siewert JR, Hofler H. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003;98:1521-1530. Medline DOI 10.1002/cncr.11660.
21. Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol 1999;17:2403-2411. Medline.